Paris, France

Eric Ogier-Denis

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eric Ogier-Denis: Innovator in Colitis Treatment

Introduction

Eric Ogier-Denis is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory bowel diseases. With a total of 3 patents, his work focuses on innovative methods for predicting treatment responses in patients suffering from acute severe colitis.

Latest Patents

One of his latest patents is titled "Methods for predicting acute severe colitis treatment response." This invention addresses the lack of biomarkers for drug response in patients with acute severe ulcerative colitis. The invention provides a prediction tool that boasts a remarkable accuracy of 96.6% in distinguishing responders from non-responders to steroid treatments. By analyzing patient biopsies, Ogier-Denis identified a classifier of fifteen colonic microRNAs and five biological values that can effectively predict treatment outcomes. Additionally, he developed algorithms based on mucosal microRNAs to classify responses to infliximab and cyclosporine.

Another significant patent is the "Method of treating an inflammatory bowel disease comprising agonists of orexin-1 receptor." This invention outlines methods and pharmaceutical compositions aimed at treating inflammatory bowel diseases. The approach involves administering a therapeutically effective amount of at least one OX1R agonist to patients in need of treatment.

Career Highlights

Throughout his career, Eric Ogier-Denis has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Paris. His research has been pivotal in advancing the understanding and treatment of inflammatory bowel diseases.

Collaborations

He has collaborated with notable professionals in the field, including Xavier Treton and Yoram Bouhnik. These partnerships have further enriched his research and contributed to the development of innovative treatment methods.

Conclusion

Eric Ogier-Denis stands out as a key figure in the medical research community, particularly for his groundbreaking work in predicting treatment responses for inflammatory bowel diseases. His inventions have the potential to significantly improve patient outcomes and advance the field of gastroenterology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…